University of Cambridge > > Wednesday Seminars - Department of Computer Science and Technology  > AI Meets Cancer

AI Meets Cancer

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact David Greaves.

Cancers are pathologies driven by genetic mutations that disrupt a multitude of signalling pathways operating across different cell types interacting in highly complex ways. No two cancers, even of the same type, are the same. The holy grail of cancer treatment is to analyse the patient’s genome and predict a sequence and combination of therapies that will destroy that patient’s cancer with no adverse side effects. By developing executable models that can simulate cancer tumours at different levels of abstraction, we are on the threshold of being able to deliver on this vision. The state-of-the-art in executable biology is the use of formal methods and software verification to describe biological systems and explore their properties. Using program synthesis methods we can directly build such models from patients’ data. This approach has already been used to find new more efficient therapies for Leukaemia in partnership with AstraZenenca. The next big question, as we collect more and more patient genomic data and history of cancer treatments, is how can we use AI methods to drive therapeutic regimes directly from patients’ data? In the talk, I will showcase recent results and share my ambitions in this space.

This talk is part of the Wednesday Seminars - Department of Computer Science and Technology series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2023, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity